Risk factor
Limited trading liquidity
Profitability factor
Undervalued vs peers
About
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, unde
Target Price
The average target price of 003850.KS is 14000 and suggests 57.7% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t